clinical trial design
How to maximize use of technology under master protocols for complex oncology studies
July 15 by Pharma IQExplore the underlying goal for using master protocols to increase the efficiency of your trial designs in 4G Clinical’s white paper
Big Book of Clinical Trial Design
October 22 by Natasha TaylorMerck, GSK, NIHR, Arena Pharma and more offer practical case studies to help you navigate your next clinical trial journey
How Valneva are changing the approach to vaccine clinical trials
September 04 by Pharma IQThomas Lingelbach, CEO of Valneva, shares how they set up their trials for success and the innovative methods that could significantly reduce trial timelines
The Importance of Innovation in Trial Design
August 02 by Pharma IQClinical development is expensive, invariably high risk and at times enormously inefficient, which is most likely the reason why productivity is sliding so rapidly in the pharmaceutical industry. Wh...
Adaptive Design in Clinical Trials: Past, Present and Future
February 25 by Pharmaceuticals & Biotechnology EditorThe Ups and Downs of Adaptive Clinical Trial Design
January 25 by Pharma IQA reduction in drug development timelines, lower clinical trial costs, improved efficacy and better trial design – all things the pharmaceutical industry constantly strives to achieve and ...
Oncology Market Leaders Must Look to Clinical Development for Future Growth
November 17 by Pharma IQOver recent years cancer drugs have moved from the traditional chemotherapies, which provided significant side effects, to more targeted therapies. However, according to a recent Reuters rep...
Adaptive and Group Sequential Clinical Methods for Clinical Trial Design
November 11 by Pharma IQChris Jennison, Professor of Statistics at the University of Bath, talks to Helen Winsor from Pharma IQ, about adaptive and group sequential clinical methods for clinical trial design and how i...
Getting a Handle on PK Parameters
October 19 by Helen WinsorThomas Jaki, lecturer at Lancaster University and an expert in the estimation of PK parameters, joins Pharma IQ to discuss the challenges and changes in this area. Pharma IQ: Thomas, welcome. So,...
Bringing Innovation to Clinical Design
September 28 by Pharma IQClinical trials may be one of the most fundamental parts of drug development work carried out in the pharmaceutical industry, but they still remain a complicated area for pharma companies to address....
Using Software to Boost Clinical Trial Design
September 20 by Pharma IQWhen considering the key challenges that new drugs face on their route to widespread use, clinical trials are undoubtedly one of the most vital. The results of such assessments play a key role...